RASFC cultures from different patients (n = 6 compounds 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 23; n = 3 compounds 21, 24, 25, 26) were treated with TNFα (10 ng mL−1) in the presence of controls or queuine analogues at a concentration of 200 μm. Culture media was replaced after 24 h and fresh media and compound were added. Cell supernatants were collected at the 72 h time point and tested for IL-6 secretion by ELISA. DMSO (4% in PBS), Tofacitinib (Xeljanz – Pfizer, Janus kinase inhibitor, 1 μM), IgG isotype antibody (1 μM) and Adalimumab (Humira – Abbvie, anti-TNF monoclonal antibody, 1 μM) served as experimental controls.
Protocol detail
Queuine analogues modulate IL-6 secretion
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Trinity College Dublin
Top 5 similar protocols
Variable analysis
independent variables
- Queuine analogues at a concentration of 200 μm
- IL-6 secretion
- DMSO (4% in PBS)
- Tofacitinib (Xeljanz – Pfizer, Janus kinase inhibitor, 1 μM)
- IgG isotype antibody (1 μM)
- Adalimumab (Humira – Abbvie, anti-TNF monoclonal antibody, 1 μM)
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!